AHA7:06Renal Denervation Science at Hypertension 2026
- Source
- AHAScience · YouTube
- Date
- Audio
- English
- Subtitles
- MultilingualYouTube
- Audio transl.
- Unconfirmed · check ⚙YouTube
Medical notice: Educational content only. CanduCardio is intended for healthcare professionals and CanduTV for the general public. It does not replace clinical judgment or professional consultation.
If you don't see subtitles in your language, turn on auto-translate from the player's settings gear (⚙).
Subtitles requested in: English
First try the player's auto-translate: settings gear (⚙) → Subtitles/CC → Auto-translate. If the video has no subtitles at all, your phone or browser can write out what is said in real time. It runs on your own device: CanduCardio receives and stores nothing.
Original title: Étude HOPE-3 portant sur la prévention des maladies cardiovasculaires (TVA Québec)
Machine-translated title; it may contain inaccuracies.
HOPE-3 (BP)2016
In intermediate-risk people without CVD, blood pressure lowering did not reduce events overall, with benefit only in the highest blood pressure tertile.
Rosuvastatin reduced cardiovascular events in ethnically diverse intermediate-risk people without cardiovascular disease.
Educational video published by IUCPQ-ULaval in 2016. Played with YouTube's official player.
AHA7:06
AHA5:42
AHA6:16
IUCPQ9:35
IUCPQ5:00
IUCPQ2:09
RadcliffeCommercial48:57
RSC30:02